The antilymphocyte antibody was positive in 84 of 407 (20. 6%) of primary transplantation patients and in 39 of 52 (75% ) of retransplantation patients.
Immunotherapy with either antithymocyte globulin (ATG) or antilymphocyte globulin (ALG) is the primary treatment for those children not candidates for bone marrow transplant.
Objective To assessed the ability of FK506 and antilymphocyte serum(ALS) to induce mixed chimerism and tolerance for knee composite tissue allograft in rabbits without chronic immunosuppression.